GFAP and myeloid sarcoma: MS has also been shown to produce beneficial effects against inflammation by downregulating the expression of GFAP and Iba-1 in the HC of Adrβ3KO and WT mice, leading to reduced glial cell activation and cytokine-mediated inflammation, and this may contribute to improved cognitive functioning and memory [36,37].